Skip to main content
main-content

Sanjay Kalra

Sanjay Kalra, MBBS, MD, DM (AIIMS New Delhi), is an endocrinologist based at Bharti Hospital, Karnal, India. An avid researcher, writer and busy clinician, he serves as President, Endocrine Society of India (ESI), Vice President of the South Asian Federation of Endocrine Societies (SAFES), and Education Editor at the International Society of Endocrinology (ISE). Along with these and other responsibilities, he works to spread endocrine and diabetes awareness across the world. In his spare time, he indulges in his favorite hobby, the Punjabi folk dance bhangra.

Latest contributions from Sanjay Kalra

07-10-2020 | EASD 2020 | Conference coverage | Article

EASD 2020: Editorial Board conference highlights

Listen to Sanjay Kalra, John Wilding and Lori Berard reflecting on their research highlights of this year’s virtual 56th EASD Annual Meeting (39:05).

24-06-2020 | ADA 2020 | Conference coverage | Article

ADA 2020 goes virtual! Editorial Board conference highlights

Listen to our Editorial Board reflecting on their ADA scientific highlights, and its novel virtual format (34:17).

25-03-2020 | Mental health | View from the clinic | Article

Glycemic happiness: Is there more to ‘good’ glucose control?

What is glycemic happiness and what are its benefits for diabetes practitioners and patients? Diabetologist Sanjay Kalra shares his view from the clinic.

03-03-2020 | Guidelines | Editorial | Article

Standards of Medical Care in Diabetes: A 2020 Update from the American Diabetes Association

Sanjay Kalra, Diabetologist and Editorial Board member, outlines what's new in the American Diabetes Association’s 2020 Standards of Care update. 

29-10-2019 | Diabetes prevention | Editorial | Article

The family and diabetes care: A multifaceted relationship

Before attention turns to World Diabetes Day 2019, Sanjay Kalra revisits 2018’s theme to evaluate the concerns and opportunities presented by “The Family and Diabetes”.

06-08-2019 | SGLT2 inhibitors | Editorial | Article

Cardiorenal syndromes and SGLT2 inhibitor usage

Sanjay Kalra explores the intrinsic link between the cardiovascular and renal systems, focusing on whether the SGLT2 inhibitor class has a role to play in diabetic patients with cardiorenal comorbidity.

22-05-2019 | Sulfonylureas | Editorial | Article

The CAROLINA trial: Make or break for sulfonylureas?

Diabetologist Sanjay Kalra puts the CAROLINA trial into historical context and considers the present-day implications for the use of DPP-4 inhibitors and sulfonylureas.

05-12-2018 | Diabetes distress | Editorial | Article

Diabetes distress: What’s in a name?

Sanjay Kalra and Psychiatrist Yatan Pal Singh Balhara question whether “diabetes distress” is well understood outside of the diabetes field and consider whether alternative terminology may help to bridge the knowledge gap.

14-11-2018 | Cardiovascular outcomes | Editorial | Article

What have I learned from cardiovascular outcome trials?

Endocrinologist Sanjay Kalra considers the impact that cardiovascular outcome trials have had on the standard of diabetes care and questions what else they might accomplish in the future.

12-09-2018 | Diet | Commentary | Article

Diet–drug interactions: Why two rights can make a wrong

Editorial Board member and Endocrinologist, Sanjay Kalra comments on the issues raised by a clinical case involving sodium glucose cotransporter 2 inhibitor therapy alongside a restrictive diet.

30-05-2018 | Insulin | Editorial | Article

Hit early, hit hard: The EADSG insulin guidelines

Sanjay Kalra and Silver Bahendeka, East Africa Diabetes Study Group Chair, provide an overview of the latest insulin guidance developed to aid management in a challenging region, facing familiar struggles.

16-05-2018 | Devices and technology | Editorial | Article

Digital diabetology

Editorial Board member Sanjay Kalra presents his view on the march toward greater integration of digital health technologies and how traditional approaches to diabetes management are already changing.

21-02-2018 | Primary care | Editorial | Article

Compassion fatigue in diabetes care professionals

Awareness and education about compassion fatigue can help to limit its incidence and severity. Sanjay Kalra outlines strategies to identify and manage the emotional exhaustion that often affects diabetes caregivers.

29-01-2018 | Diabetic foot ulcers | Editorial | Article

Diabetes in special situations: Insulin in diabetic foot ulcers

Formal guidance addressing the optimal use of insulin therapy in diabetic foot ulcer patients is lacking. Editorial Board member Sanjay Kalra and Banshi Saboo present their pragmatic approach to treatment.

05-12-2017 | Insulin resistance | Editorial | Article

A pragmatic and practical guide to U500 regular insulin usage

Editorial Board member Sanjay Kalra shares his pragmatic and practical suggestions on initiating, monitoring, and titrating suitable patients on U500 regular insulin.

22-11-2017 | Cardiovascular disorders | Editorial | Article

Diabetes in special situations: Sodium-glucose co-transporter-2 inhibitors in acute coronary syndrome

Editorial Board member Sanjay Kalra presents a pragmatic approach to the use of sodium-glucose co-transporter-2 inhibitors in patients affected by acute coronary syndromes.

13-11-2017 | Gestational diabetes | Editorial | Article

Gestational diabetes mellitus: Opportunity, not despair

Should gestational diabetes mellitus be viewed as an opportunity, or an inequality, and should it be a cause for dynamism or despair? Sanjay Kalra and Ankia Coetzee present their perspective on gestational diabetes mellitus.

23-10-2017 | Cardiovascular disorders | Editorial | Article

Diabetes in special situations: Glucagon-like peptide-1 receptor agonist use in acute myocardial infarction

Editorial Board member Sanjay Kalra presents a pragmatic approach to the use of glucagon-like peptide-1 receptor agonists in patients affected by acute myocardial infarction.

25-11-2016 | Insulin | Editorial | Article

Choosing an insulin delivery device

A process of shared and informed decision-making, facilitated by demonstration, helps ensure that the right delivery device is chosen and prescribed for persons who require insulin.

Image Credits